Found: 40
Select item for more details and to access through your institution.
WIN site inhibition disrupts a subset of WDR5 function.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-05947-9
- By:
- Publication type:
- Article
Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc.
- Published in:
- EMBO Journal, 1999, v. 18, n. 3, p. 717, doi. 10.1093/emboj/18.3.717
- By:
- Publication type:
- Article
A conserved element in Myc that negatively regulates its proapoptotic activity.
- Published in:
- EMBO Reports, 2005, v. 6, n. 2, p. 177, doi. 10.1038/sj.embor.7400333
- By:
- Publication type:
- Article
Old dogs and new tricks.
- Published in:
- 2002
- By:
- Publication type:
- Report
MYC regulates ribosome biogenesis and mitochondrial gene expression programs through its interaction with host cell factor-1.
- Published in:
- eLife, 2021, p. 1, doi. 10.7554/eLife.60191
- By:
- Publication type:
- Article
T lymphocyte reconstitution following autologous bone marrow transplantation.
- Published in:
- Clinical & Experimental Immunology, 1983, v. 51, n. 2, p. 455
- By:
- Publication type:
- Article
The ubiquitin-selective chaperone Cdc48/p97 associates with Ubx3 to modulate monoubiquitylation of histone H2B.
- Published in:
- Nucleic Acids Research, 2014, v. 42, n. 17, p. 10975, doi. 10.1093/nar/gku786
- By:
- Publication type:
- Article
Emerging Themes in Mechanisms of Tumorigenesis by SWI/SNF Subunit Mutation.
- Published in:
- Epigenetics Insights, 2022, p. 1, doi. 10.1177/25168657221115656
- By:
- Publication type:
- Article
Emerging Themes in Mechanisms of Tumorigenesis by SWI/SNF Subunit Mutation.
- Published in:
- Epigenetics Insights, 2022, v. 15, p. 1, doi. 10.1177/25168657221115656
- By:
- Publication type:
- Article
How the ubiquitin-proteasome system controls transcription.
- Published in:
- Nature Reviews Molecular Cell Biology, 2003, v. 4, n. 3, p. 192, doi. 10.1038/nrm1049
- By:
- Publication type:
- Article
A common functional consequence of tumor-derived mutations within c-MYC.
- Published in:
- Oncogene, 2015, v. 34, n. 18, p. 2406, doi. 10.1038/onc.2014.186
- By:
- Publication type:
- Article
Peripheral blood progenitor cell mobilisation in patients with multiple myelo following oral idarubicin and dexamethasone (Z-Dex) induction therapy.
- Published in:
- Leukemia (08876924), 1997, v. 11, p. S35
- By:
- Publication type:
- Article
WD Repeat Domain 5 Inhibitors for Cancer Therapy: Not What You Think.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 1, p. 274, doi. 10.3390/jcm13010274
- By:
- Publication type:
- Article
Functions of the Proteasome on Chromatin.
- Published in:
- Biomolecules (2218-273X), 2014, v. 4, n. 4, p. 1026, doi. 10.3390/biom4041026
- By:
- Publication type:
- Article
Multiple cell-type-specific elements regulate Myc protein stability.
- Published in:
- 2004
- By:
- Publication type:
- Correction Notice
Multiple cell-type-specific elements regulate Myc protein stability.
- Published in:
- Oncogene, 2004, v. 23, n. 21, p. 3863, doi. 10.1038/sj.onc.1207492
- By:
- Publication type:
- Article
Stable and unstable pools of Myc protein exist in human cells.
- Published in:
- Oncogene, 2002, v. 21, n. 55, p. 8515, doi. 10.1038/sj.onc.1205976
- By:
- Publication type:
- Article
Regulation of c-myc stability by selective stress conditions and by MEKK1 requires aa 127 - 189 of c-myc.
- Published in:
- Oncogene, 2002, v. 21, n. 28, p. 4384, doi. 10.1038/sj.onc.1205543
- By:
- Publication type:
- Article
Inhibition of MYC by the SMARCB1 tumor suppressor.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-10022-5
- By:
- Publication type:
- Article
Super-Enhancer Dysregulation in Rhabdoid Tumor Cells Is Regulated by the SWI/SNF ATPase BRG1.
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 916, doi. 10.3390/cancers16050916
- By:
- Publication type:
- Article
Elevating SOX2 Downregulates MYC through a SOX2:MYC Signaling Axis and Induces a Slowly Cycling Proliferative State in Human Tumor Cells.
- Published in:
- Cancers, 2022, v. 14, n. 8, p. 1946, doi. 10.3390/cancers14081946
- By:
- Publication type:
- Article
Gal4 turnover and transcription activation.
- Published in:
- Nature, 2009, v. 461, n. 7265, p. E7, doi. 10.1038/nature08406
- By:
- Publication type:
- Article
Ribosome subunit attrition and activation of the p53-MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition.
- Published in:
- eLife, 2024, p. 1, doi. 10.7554/eLife.90683
- By:
- Publication type:
- Article
Transcriptional regulation: RUPture in the ER.
- Published in:
- Nature Cell Biology, 2000, v. 2, n. 10, p. E175, doi. 10.1038/35036420
- By:
- Publication type:
- Article
Mitotic gene regulation by the N-MYC-WDR5-PDPK1 nexus.
- Published in:
- BMC Genomics, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12864-024-10282-6
- By:
- Publication type:
- Article
Antifoam effects on ultrafiltration.
- Published in:
- Biotechnology & Bioengineering, 1988, v. 31, n. 4, p. 385, doi. 10.1002/bit.260310416
- By:
- Publication type:
- Article
Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.
- Published in:
- Nature, 2005, v. 436, n. 7052, p. 807, doi. 10.1038/nature03845
- By:
- Publication type:
- Article
Synergistic action of WDR5 and HDM2 inhibitors in SMARCB1-deficient cancer cells.
- Published in:
- NAR Cancer, 2022, v. 4, n. 1, p. 1, doi. 10.1093/narcan/zcac007
- By:
- Publication type:
- Article
Letter to the Editor.
- Published in:
- Yeast, 2012, v. 29, n. 2, p. 93, doi. 10.1002/yea.1919
- By:
- Publication type:
- Article
Combined chemical and genetic approach to inhibit proteolysis by the proteasome.
- Published in:
- 2010
- By:
- Publication type:
- Other
How Cells Use Proteolysis to Control Their Growth.
- Published in:
- Molecular Medicine, 2012, v. 18, n. 12, p. 773
- By:
- Publication type:
- Article
WDR5 is a conserved regulator of protein synthesis gene expression.
- Published in:
- Nucleic Acids Research, 2020, v. 48, n. 6, p. 2924, doi. 10.1093/nar/gkaa051
- By:
- Publication type:
- Article
Reversal of asymptomatic over-anticoagulation with oral vitamin K.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Targeting what is not there to treat cancer.
- Published in:
- BioEssays, 2023, v. 45, n. 7, p. 1, doi. 10.1002/bies.202300064
- By:
- Publication type:
- Article
WDR5 facilitates recruitment of N-MYC to conserved WDR5 gene targets in neuroblastoma cell lines.
- Published in:
- Oncogenesis, 2023, v. 12, n. 1, p. 1, doi. 10.1038/s41389-023-00477-z
- By:
- Publication type:
- Article
The SWI/SNF ATPase BRG1 facilitates multiple pro-tumorigenic gene expression programs in SMARCB1-deficient cancer cells.
- Published in:
- Oncogenesis, 2022, v. 11, n. 1, p. 1, doi. 10.1038/s41389-022-00406-6
- By:
- Publication type:
- Article
Treatment of chronic myeloid leukaemia in first chronic phase with idarubicin and cytarabine: mobilization of Philadelphia-negative peripheral blood stem cells.
- Published in:
- British Journal of Haematology, 1997, v. 96, n. 3, p. 627, doi. 10.1046/j.1365-2141.1997.d01-2058.x
- By:
- Publication type:
- Article
A phase I/II trial of Z-Dex (oral idarubicin and dexamethasone), an oral equivalent of VAD, as initial therapy at diagnosis or progression in multiple myeloma.
- Published in:
- British Journal of Haematology, 1996, v. 93, n. 4, p. 931, doi. 10.1046/j.1365-2141.1996.d01-1715.x
- By:
- Publication type:
- Article
SECONDARY ACUTE MYELOID LEUKAEMIA: A HETEROGENEOUS ENTITY?
- Published in:
- British Journal of Haematology, 1985, v. 59, n. 1, p. 192, doi. 10.1111/j.1365-2141.1985.tb02982.x
- By:
- Publication type:
- Article
Haematological reconstitution following high dose and supralethal chemo-radiotherapy using stored, non-cryopreserved autologous bone marrow.
- Published in:
- British Journal of Haematology, 1983, v. 54, n. 2, p. 309, doi. 10.1111/j.1365-2141.1983.tb02100.x
- By:
- Publication type:
- Article